RCM earnings
R1 RCM Inc. (RCM) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 BillionMURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.
- R1 RCM to Release Second Quarter 2024 Results on August 7, 2024MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341. A live webcast and replay of the call will be available at the Investor Relations s
- R1 RCM Reports First Quarter 2024 ResultsMURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss of $35.1 million, compared to net income of $1.6 million in the same period last year.Adjusted EBITDA of $152.2 million, compared to adjusted EBI
- R1 RCM to Release First Quarter 2024 Results on May 8, 2024MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341. A live webcast and replay of the call will be available at the Investor Relations
- R1 RCM Reports Fourth Quarter and Full Year 2023 ResultsMURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023. Fourth Quarter 2023 Results: Revenue of $575.1 million, up $41.8 million or 7.8% compared to the same period last yearGAAP net income of $1.4 million, compared to a net loss of $36.6 million in the same period last yearAdjusted EBITDA of $167.7 million, up $42.1 million or 33.5% compared to the same period last year Full Year 2023 Results: Revenue
- R1 RCM Completes Acquisition of Acclara, Providence's Modular Services BusinessCompany Enters 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services to Providence Company to Release Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Outlook on February 27, 2024 MURRAY, Utah, Jan. 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has completed its previously announced acquisition of Acclara from Providence, one of the nation's largest health systems. In addition, the Company announced that it expects to release financial results for the fourth quarter a
- R1 RCM to Acquire AcclaraAcquisition of Providence's Current Modular Services Business Accompanied by 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services R1 to Host Conference Call Today at 8:00 AM ET MURRAY, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to acquire Acclara, a leading technology-driven revenue cycle management company, from Providence, one of the nation's largest health systems; and the Company has been selected by Providence as its long-term re
- R1 RCM Reports Third Quarter 2023 ResultsMURRAY, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2023. Third Quarter 2023 Results: Revenue of $572.8 million, up $76.8 million or 15.5% compared to the same period last year.GAAP net income of $1.3 million, compared to net loss of $29.5 million in the same period last year.Adjusted EBITDA of $161.5 million, up $37.5 million or 30.2% compared to the same period last year. "Our strong third quarter results demonstrate our team's dedication to innovatio
- R1 RCM to Release Third Quarter 2023 Results on November 2MURRAY, Utah, Oct. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended September 30, 2023, before market open on Thursday, November 2, 2023. R1's management team will host a conference call on November 2 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations sec
- R1 RCM Reports Second Quarter 2023 ResultsMURRAY, Utah, Aug. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2023. Second Quarter 2023 Results: Revenue of $560.7 million, up $168.8 million or 43.1% compared to the same period last year.GAAP net income of $0.3 million, compared to net loss of $20.4 million in the same period last year.Adjusted EBITDA of $142.9 million, up $55.7 million or 63.9% compared to the same period last year.GAAP net income and adjusted EBITDA were negatively impacted by an $11.6 million increase
- R1 RCM to Release Second Quarter 2023 Results on August 2MURRAY, Utah, July 12, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2023, before market open on Wednesday, August 2, 2023. R1's management team will host a conference call on August 2 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations section of
- R1 RCM Reports First Quarter 2023 ResultsMURRAY, Utah, May 04, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended March 31, 2023. First Quarter 2023 Results: Revenue of $545.6 million, up $159.9 million or 41.5% compared to the same period last year.GAAP net income of $0.3 million, compared to $29.4 million in the same period last year.Adjusted EBITDA of $142.2 million, up $52.9 million or 59.2% compared to the same period last year. "Our strong first quarter results demonstrate the team's focus on execution and our ability to deliver value
- R1 RCM to Release First Quarter 2023 Results on May 4MURRAY, Utah, April 18, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2023, before market open on Thursday, May 4, 2023. R1's management team will host a conference call on May 4 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations section of the C
- R1 RCM Reports Fourth Quarter and Full Year 2022 ResultsMURRAY, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2022. Fourth Quarter 2022 Results: Revenue of $532.8 million, up $133.9 million or 33.6% compared to the same period last yearGAAP net loss of $37.1 million, compared to net income of $36.0 million in the same period last yearAdjusted EBITDA of $125.0 million, up $29.9 million or 31.4% compared to the same period last year Full Year 2022 Results: Revenue of $1,806.4 million, up $331.8 million or 22.5% com
- R1 RCM to Release Fourth Quarter 2022 Results on February 16MURRAY, Utah, Jan. 26, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months and full year ended December 31, 2022, before market open on Thursday, February 16, 2023. R1's management team will host a conference call on February 16 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Inv
- R1 RCM Announces Leadership Succession PlanLee Rivas Appointed Chief Executive Officer, effective January 1, 2023; Joseph Flanagan to Continue Serving on Board John Sparby, Chief Operating Officer, Appointed President MURRAY, Utah, Nov. 08, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that its Board of Directors has appointed Lee Rivas to succeed Joseph Flanagan as Chief Executive Officer, effective January 1, 2023, at which time Mr. Rivas will also join the Company's Board. Mr. Flanagan will step down effective January 1, 2023, following a distin
- R1 RCM Reports Third Quarter 2022 ResultsMURRAY, Utah, Nov. 08, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2022. Third Quarter 2022 Results: Revenue of $496.0 million, up $116.3 million or 30.6% compared to the same period last year.GAAP net loss of $29.5 million, compared to net income of $17.0 million in the same period last year. GAAP net loss was negatively impacted by a $9.5 million increase in allowance for credit losses.Adjusted EBITDA of $124.0 million, up $34.7 million or 38.9% compared to the same peri
- R1 RCM to Release Third Quarter 2022 Results on November 8MURRAY, Utah, Oct. 19, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended September 30, 2022, before market open on Tuesday, November 8, 2022. R1's management team will host a conference call on November 8 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations se
- R1 RCM Reports Second Quarter 2022 ResultsMURRAY, Utah, Aug. 03, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2022. Second Quarter 2022 Results: Revenue of $391.9 million, up $38.5 million or 10.9% compared to the same period last year GAAP net loss of $20.4 million, compared to net income of $18.4 million in the same period last year. GAAP net loss of $20.4 million was primarily driven by $74.4 million of expenses related to completion of the Cloudmed acquisition. Adjusted EBITDA of $87.2 million, up $8.4 million or 10.7% co
- R1 RCM to Release Second Quarter 2022 Results on August 3MURRAY, Utah, July 20, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2022 before market open on Wednesday, August 3, 2022. R1's management team will host a conference call on August 3 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations section of
- R1 RCM Completes Acquisition of CloudmedCombined company to deliver a scalable, flexible, and integrated platform to optimize revenue cycle and consumer engagement in healthcare R1 to Host Conference Call on June 27 at 4:30pm ET MURRAY, Utah, June 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it has completed its previously announced acquisition of Cloudmed. Together the companies will be positioned to deliver a leading platform for healthcare provider revenue cycle management (RCM) and drive further digital transformation through automation and AI. With ext
- R1 RCM Reports First Quarter 2022 ResultsMURRAY, Utah, May 09, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended March 31, 2022. First Quarter 2022 Results: Revenue of $385.7 million, up $43.1 million or 12.6% compared to the same period last year GAAP net income of $29.4 million, up $3.6 million or 14.0% compared to the same period last year Adjusted EBITDA of $89.3 million, up $8.9 million or 11.1% compared to the same period last year "Our team remains highly committed to delivering strong results to our customers and the patients the
- R1 RCM to Release First Quarter 2022 Results on May 9MURRAY, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2022 before market open on Monday, May 9, 2022. R1's management team will host a conference call on May 9 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations section of the
- R1 RCM Reports Fourth Quarter and Full Year 2021 ResultsMURRAY, Utah, Feb. 17, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2021. Fourth Quarter 2021 Results: Revenue of $398.9 million, up $70.5 million or 21.5% compared to the same period last yearGAAP net income of $36.0 million, down $42.6 million or 54.2% compared to the same period last year due to a $55.7 million gain on business disposition in the fourth quarter of 2020. Excluding this gain, GAAP net income would have increased 57.2% compared to the same period last year.
- R1 RCM to Release Fourth Quarter 2021 Results on February 17MURRAY, Utah, Jan. 31, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months and full year ended December 31, 2021 before market open on Thursday, February 17, 2022. R1's management team will host a conference call on February 17 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Invest
- R1 RCM to Acquire Cloudmed, Creating the Strategic Revenue Partner for Healthcare ProvidersAdvances Integrated Technology Strategy Through EnhancedRevenue Intelligence and Expanded Automation Opportunity R1 to Host Conference Call Today at 7:00 a.m. ET MURRAY, Utah and ATLANTA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to acquire Cloudmed, a leader in Revenue Intelligence™ solutions for healthcare providers, in an all-stock transaction. The transaction values Cloudmed at approximately $4.1 billion, including $857 million of net debt, based on R1's clos
- R1 RCM Reports Third Quarter 2021 ResultsMURRAY, Utah, Nov. 02, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2021. Third Quarter 2021 Results: Revenue of $379.7 million, up $72.5 million or 23.6% compared to the same period last year GAAP net income of $17.0 million, up $11.8 million or 226.9% compared to the same period last year Adjusted EBITDA of $89.3 million, up $38.9 million or 77.2% compared to the same period last year "Our third quarter results demonstrate continued strong execution across our business, thanks
- R1 RCM to Release Third Quarter 2021 Results on November 2MURRAY, Utah, Oct. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended September 30, 2021 before market open on Tuesday, November 2, 2021. R1's management team will host a conference call on November 2 at 8:00 a.m. ET to discuss the results and business outlook. To participate, please dial 888-330-2022 (646-960-0690 outside the U.S. and Canada) using conference code number 5681952. A live webcast and replay of the call will be available at the Investor Relations secti
- R1 RCM Reports Second Quarter 2021 Results; Raises 2021 GuidanceMURRAY, Utah, Aug. 03, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2021. Second Quarter 2021 Results: Revenue of $353.4 million, up $38.7 million or 12.3% compared to the same period last year GAAP net income of $18.4 million, up $3.3 million or 21.9% compared to the same period last year Adjusted EBITDA of $78.8 million, up $13.5 million or 20.7% compared to the same period last year "Our second quarter results demonstrate the continued momentum in our business, driven by strong op